HomeInsightsStock Comparison

Jagsonpal Pharmaceuticals Ltd vs Procter Gamble Health Ltd Stock Comparison

Jagsonpal Pharmaceuticals Ltd vs Procter Gamble Health Ltd Stock Comparison

Last Updated on: May 30, 2025

Key Highlights

  • The Latest Trading Price of Jagsonpal Pharmaceuticals Ltd is ₹ 236.95 as of 30 May 15:30.
  • The p/e ratio of Jagsonpal Pharmaceuticals Ltd changed from 5.8 to 32.9 over 5 quarters. This represents a CAGR of 300.88% The p/e ratio of Procter & Gamble Health Ltd changed from 39.9 to 0 over 10 quarters. This represents a CAGR of -100.00% .
  • The market cap of Jagsonpal Pharmaceuticals Ltd changed from ₹ 45.72 crore to ₹ 737.06 crore over 5 quarters. This represents a CAGR of 824.52% The market cap of Procter & Gamble Health Ltd changed from ₹ 6751 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of -100.00% .
  • The revenue of Jagsonpal Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 61.33 crore. This represent the decline of -100% The revenue of Procter & Gamble Health Ltd for the Dec '25 is ₹ 314.1 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the growth of 9.2233718E16%.
  • The ebitda of Jagsonpal Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 11.27 crore. This represent the decline of -100% The ebitda of Procter & Gamble Health Ltd for the Dec '25 is ₹ 84.03 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the growth of 9.2233718E16%.
  • The net profit of Jagsonpal Pharmaceuticals Ltd changed from ₹ 3.96 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The net profit of Procter & Gamble Health Ltd changed from ₹ 59.19 crore to ₹ 61.18 crore over 9 quarters. This represents a CAGR of 1.48% .
  • The dividend payout of Jagsonpal Pharmaceuticals Ltd changed from 16.65 % to 58.86 % over 5 quarters. This represents a CAGR of 174.62% The dividend payout of Procter & Gamble Health Ltd changed from 150.27 % to 0 % over 10 quarters. This represents a CAGR of -100.00% .

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Jagsonpal Pharmaceuticals Ltd

  • Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana.
  • The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs.
  • Simultaneously, it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd. The company has a strategic alliance with Fidia Spa, Italy; and B Spofola, Czechoslovakia; to manufacture sophisticated drugs in India.
  • It has tied up with another Israel-based company, Makhteshim Chemical Works, for acquiring the marketing rights of an anti-oxidant product.
  • In 1994, the company has also promoted Aresco Financial Services, a new financial company.

About Procter & Gamble Health Ltd

  • Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in year 1967.
  • The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
  • Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
  • The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
  • The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

Jagsonpal Pharmaceuticals Ltd News Hub

News

Board of Jagsonpal Pharmaceuticals recommends final dividend

Jagsonpal Pharmaceuticals announced that the Board of Directors of the Company at its meet...

Read more

07 May 2025 09:28

News

Jagsonpal Pharmaceuticals to announce Quarterly Result

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on ...

Read more

30 Apr 2025 10:51

News

Jagsonpal Pharmaceuticals allots 39,850 equity shares under ESOP

Jagsonpal Pharmaceuticals has allotted 39,850 equity shares under ESOP. With this allotmen...

Read more

21 Apr 2025 14:14

News

Jagsonpal Pharmaceuticals allots 11,575 equity shares under ESOP

Jagsonpal Pharmaceuticals has allotted 11,575 equity shares under ESOP. Consequent to the ...

Read more

13 Mar 2025 18:58

News

Jagsonpal Pharmaceuticals allots 22,150 equity shares under ESOP

Jagsonpal Pharmaceuticals has allotted 22,150 equity shares of Rs. 2/- each under JPL ESOP...

Read more

17 Feb 2025 12:41

News

Jagsonpal Pharma gains after reporting strong Q3 numbers

Revenue from operations surged 56.7% to Rs 74.03 crore recorded in the quarter ended 31 De...

Read more

23 Jan 2025 12:45

Procter & Gamble Health Ltd News Hub

News

Board of Procter & Gamble Health recommends final dividend

Procter & Gamble Health announced that the Board of Directors of the Company at its meetin...

Read more

30 May 2025 11:27

News

Procter & Gamble Health declare Quarterly Result

Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 29...

Read more

27 Mar 2025 10:23

News

P&G Health gains as Q3 PAT jumps 26% YoY to Rs 91 cr; declares interim dividend of Rs 80/share

The company's revenue from operations remained flat to Rs 309.77 crore in Q3 FY25, compare...

Read more

12 Feb 2025 15:45

News

Board of Procter & Gamble Health recommends interim dividend

Procter & Gamble Health announced that the Board of Directors of the Company at its meetin...

Read more

12 Feb 2025 16:37

News

Procter & Gamble Health announces board meeting date

Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 12...

Read more

28 Dec 2024 09:36

News

P&G Health hits 52 week high as Q2 PAT jumps 26% YoY to Rs 82 cr

Profit before tax in Q2 FY25 stood at Rs 111.4 crore, up 26.51% as against Rs 88.05 crore ...

Read more

05 Nov 2024 09:59

SWOT Analysis Of Procter & Gamble Health Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Jagsonpal Pharmaceuticals Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Procter & Gamble Health Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Jagsonpal Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Jagsonpal Pharmaceuticals Ltd and Procter & Gamble Health Ltd

Which company has a larger market capitalization, Jagsonpal Pharmaceuticals Ltd or Procter & Gamble Health Ltd?

Market cap of Jagsonpal Pharmaceuticals Ltd is 1,574 Cr while Market cap of Procter & Gamble Health Ltd is 9,587 Cr

What are the key factors driving the stock performance of Jagsonpal Pharmaceuticals Ltd and Procter & Gamble Health Ltd?

The stock performance of Jagsonpal Pharmaceuticals Ltd and Procter & Gamble Health Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jagsonpal Pharmaceuticals Ltd and Procter & Gamble Health Ltd?

As of May 30, 2025, the Jagsonpal Pharmaceuticals Ltd stock price is INR ₹236.95. On the other hand, Procter & Gamble Health Ltd stock price is INR ₹5775.85.

How do dividend payouts of Jagsonpal Pharmaceuticals Ltd and Procter & Gamble Health Ltd compare?

To compare the dividend payouts of Jagsonpal Pharmaceuticals Ltd and Procter & Gamble Health Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions